NEKTAR THERAPEUTICS (INDIA) PRIVATE LIMITED
OVERVIEW - NEKTAR THERAPEUTICS (INDIA) PRIVATE LIMITED
Nektar Therapeutics (India) Private Limited is an unlisted private company incorporated on 16 May, 2005. It is classified as a private subsidiary of a foreign company and is located in Hyderabad, Telangana. It's authorized share capital is INR 30.00 cr and the total paid-up capital is INR 29.39 cr.
Nektar Therapeutics (India)'s operating revenues range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 12.12 % over the previous year. At the same time, it's book networth has decreased by -16.12 %. Other performance and liquidity ratios are available here.
Description: The company is a manufacturer of general intranvenous fluids, ffs technology intranvenous fluids & who-gmp standards intranvenous fluids.
Products & Services: Pro Drug Conjugates, Nektar Polymar, Cell Membarance, Intra Cellular Receptor, Large Molecule Polymer Conjugates, Antibody Fragment Conjugates
Category: Manufacturer
The current status of Nektar Therapeutics (India) Private Limited is - Active.
The last reported AGM (Annual General Meeting) of Nektar Therapeutics (India) Private Limited, per our records, was held on 28 September, 2023.
Nektar Therapeutics (India) Private Limited has two directors - Ramesh Panchagnula and Mark Andrew Wilson.
The Corporate Identification Number (CIN) of Nektar Therapeutics (India) Private Limited is U24239TG2005FTC046253. The registered office of Nektar Therapeutics (India) Private Limited is at P.NO.1-8-304 TO 307/10&11, 2ND FLOOR,SHYAM ARIHANT PATIGADDA ROAD, BEGUMPET, HYDERABAD, Hyderabad, Telangana.
REGISTERED DETAILS - NEKTAR THERAPEUTICS (INDIA) PRIVATE LIMITED
CIN
U24239TG2005FTC046253
Incorporation Date / Age
16 May, 2005 / 19 yrs
Last Reported AGM Date
28 September, 2023
Authorized Capital
INR 3000.0 Lacs
Paidup Capital
INR 2939.1 Lacs
industry*
Manufacturing (Chemicals and chemical products)
type
Unlisted Private Company
category
Company limited by Shares
subcategory
Subsidiary of Foreign Company
Email Address
Login for email address. This is to prevent spam.
Website
https://www.nektar.com. (Incorrect website?)
Registered Address
P.NO.1-8-304 TO 307/10&11, 2ND FLOOR,SHYAM ARIHANT
PATIGADDA ROAD, BEGUMPET
HYDERABAD
Hyderabad - 500003
Telangana - India
FINANCIAL HIGHLIGHTS - NEKTAR THERAPEUTICS (INDIA) PRIVATE LIMITED
| Operating Revenue | INR 1 cr - 100 cr |
| EBITDA | 12.12 % |
| Networth | -16.12 % |
| Debt/Equity Ratio | 0.23 |
| Return on Equity | -19.21 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
Directors - NEKTAR THERAPEUTICS (INDIA) PRIVATE LIMITED
The company has 2 directors and 1 reported key management personnel.
The longest serving director currently on board is Ramesh Panchagnula who was appointed on 24 July, 2012. Ramesh Panchagnula has been on the board for more than 11 years. The most recently appointed director is Mark Andrew Wilson, who was appointed on 19 March, 2019.
Ramesh Panchagnula has the largest number of other directorships with a seat at a total of 1 companies. In total, the company is connected to 0 other companies through its directors.
| NAME | DESIGNATION | APPOINTMENT DATE | |
|---|---|---|---|
| RAMESH PANCHAGNULA | Director | 24 July, 2012 | No other directorships |
| MARK ANDREW WILSON | Director | 19 March, 2019 | No other directorships |
| PHANEENDRA MODALI | KMP | 16 July, 2018 | No other directorships |
Previous Names
| No previous names were found for this company. |
Previous CINs
| No previous CINs were found for this company. |
SIMILAR COMPANIES
| NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
|---|---|---|---|---|
|
SAUMYA MEDICAL CARE AND MEDIA LIMITED
It was formed in year 1993 in Andhra Pradesh . The company currently has a paid up capital of INR 29.47 cr.
|
1993 | Andhra Pradesh | 29.47 cr | Buy financial reports |
|
HERBOCHEM INDUSTRIES PRIVATE LIMITED
It was formed in year 2021 in Uttar Pradesh . The company currently has a paid up capital of INR 29.58 cr.
|
2021 | Uttar Pradesh | 29.58 cr | Buy financial reports |
|
DEEPAK NOVOCHEM SPECIALITIES LIMITED
It was formed in year 2022 in Gujarat . The company currently has a paid up capital of INR 29.60 cr.
|
2022 | Gujarat | 29.60 cr | Buy financial reports |
|
LOZEN PHARMA PRIVATE LIMITED
It was formed in year 2009 in Karnataka . The company currently has a paid up capital of INR 29.63 cr.
|
2009 | Karnataka | 29.63 cr | Buy financial reports |
|
PARIJAT INDUSTRIES (INDIA) PRIVATE LIMITED
It was formed in year 1995 in Delhi . The company currently has a paid up capital of INR 29.64 cr.
|
1995 | Delhi | 29.64 cr | Buy financial reports |
|
JAGADISHWAR PHARMACEUTICAL WORKS LIMITED
It was formed in year 1987 in Assam . The company currently has a paid up capital of INR 29.70 cr.
|
1987 | Assam | 29.70 cr | Buy financial reports |
|
PREMIER MEDICAL CORPORATION PRIVATE LIMITED
It was formed in year 1996 in Gujarat . The company currently has a paid up capital of INR 29.08 cr.
|
1996 | Gujarat | 29.08 cr | Buy financial reports |
|
HUMAN BIOSCIENCES INDIA LIMITED
It was formed in year 2000 in Delhi . The company currently has a paid up capital of INR 29.06 cr.
|
2000 | Delhi | 29.06 cr | Buy financial reports |
|
SUZEN MEDICARE PRIVATE LIMITED
It was formed in year 2014 in Telangana . The company currently has a paid up capital of INR 29.76 cr.
|
2014 | Telangana | 29.76 cr | Buy financial reports |
|
ATUL BIOSCIENCE LIMITED
It was formed in year 1997 in Gujarat . The company currently has a paid up capital of INR 29.02 cr.
|
1997 | Gujarat | 29.02 cr | Buy financial reports |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More